Methadone Clinics in Connecticut

Methadone clinics in Connecticut offer medication assisted treatment options for opiate addiction. These programs reduce the withdrawal symptoms and curb cravings allowing users to have a more productive and effective recovery.

Methadone Clinics in cities of Connecticut

Medication Treatment for Opioid Use Disorder Across Connecticut

Connecticut runs one of the more accessible state systems for opioid use disorder (OUD) care in the country, and the numbers have been moving in the right direction. Confirmed overdose deaths fell to 990 in 2024 from 1,338 in 2023, the third straight year of decline, with about 76% of those deaths involving fentanyl.

The state covers all three FDA-approved medications for opioid use disorder (MOUD) through its Medicaid program, and a single 24/7 phone line connects residents to assessment and treatment statewide. Use the listings on this page or the helpline below to reach a provider, then read on for how access, coverage, and the medications work in Connecticut.

Three Medications for Opioid Use Disorder Treatment

There are three medications approved for opioid use disorder, and they are offered in two kinds of settings. Methadone for opioid use disorder is provided only through licensed opioid treatment programs (OTPs), not regular pharmacies. You go to the program to be dosed, with take-home doses earned over time based on stability.

Buprenorphine, including Suboxone and other buprenorphine-naloxone films and tablets, works differently. It can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside an OTP. There is also an extended-release injectable form, Sublocade, given monthly.

Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but treatment starts only after a person has stopped using opioids for a set time, so a clinician plans the timing.

That office-versus-clinic split is the single most useful thing to understand before you call. An opioid treatment program (OTP) handles methadone and can also offer buprenorphine and naltrexone.

Office-based opioid treatment (OBOT) means a regular medical practice prescribing buprenorphine or naltrexone, often with telehealth visits. If you want to weigh the trade-offs, see how methadone and Suboxone compare, read more about how methadone treatment works, or learn what to expect at a methadone clinic. Which medication fits is a decision to make with a clinician, not something any directory should decide for you.

State Rules, Medicaid Coverage, and How Connecticut Pays for Treatment

Connecticut’s Medicaid program, HUSKY Health, covers all three medications for opioid use disorder. Connecticut is unusual in running HUSKY as a fee-for-service program rather than through private managed care organizations, so the state pays providers directly and there are fewer plan-by-plan coverage hoops than in most states.

Buprenorphine, buprenorphine-naloxone, and Suboxone are covered as a pharmacy benefit, and HUSKY does not require enrollment in counseling as a condition of getting medication. If you earn slightly too much for HUSKY, Covered Connecticut offers no-cost coverage including substance use treatment for eligible adults up to 175% of the federal poverty level.

Private insurance, Medicare, and self-pay or sliding-scale arrangements at individual programs are also options. On top of coverage, the federal rules that govern treatment are current and worth knowing. Since 2023, any provider with a standard DEA registration can prescribe buprenorphine for opioid use disorder, which widened where people can get it.

Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for stable patients, decided by the program), allowed treatment to start by telehealth, and removed older barriers to admission. As of June 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit.

Those rules are viable through the end of 2026 and are still being finalized, so confirm what is current with a provider. Methadone for opioid use disorder remains dispensed through an OTP. The Department of Mental Health and Addiction Services (DMHAS) is the State Opioid Treatment Authority that oversees this system.

For patients transferring in or worried about continuity, keeping a steady methadone dose matters during any move, and there are privacy protections worth understanding around treatment and employment.

The Opioid Picture in Connecticut Right Now

The trend in Connecticut is genuinely encouraging, and it is the result of sustained public-health work rather than chance. Confirmed drug overdose deaths dropped to 990 in 2024 from 1,338 the year before, a roughly 26% decline and the third consecutive annual decrease. Fentanyl remained involved in about 76% of those deaths, and the state has tracked rising contamination from xylazine and emerging substances like nitazenes and carfentanil in its drug supply.

State officials have credited the decline in part to saturating communities with naloxone and to expanded access to treatment. Behind every figure is a person and a family, and the practical takeaway is steady. Medication treatment for opioid use disorder is effective and it is available across Connecticut, and starting it is the single most protective step. You can find more background on opioid use disorder and how it is treated.

How to Find and Start Treatment in Connecticut

The fastest front door in Connecticut is the DMHAS 24/7 Access Line at 1-800-563-4086, operated by Wheeler. Staff screen your situation, explain medication options, and connect you to a same-day walk-in assessment center or an outpatient program, and they can arrange transportation to detox or residential care when needed.

The state also runs a Bed Availability website that updates daily so you can see real openings in detox, residential, and recovery-house programs. Intake usually starts with an assessment to match you to the right level of care, then induction onto medication.

If you are coming off fentanyl, starting buprenorphine too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician times the first dose carefully. This is something to plan, not to fear. Read more about methadone treatment for fentanyl addiction and the broader options for opioid addiction treatment, including the difference from inpatient care.

To find a provider near you, use the listings on this page and the city directories below.

Pregnancy, Parenting, and Justice-Involved Care in Connecticut

Connecticut has built specific programs for situations that carry higher stakes, and it has been deliberate about lowering the fear that keeps people away. For pregnant and parenting people, medication treatment is the recommended standard of care, and Connecticut’s Department of Children and Families states plainly that prenatal substance exposure alone is not grounds to substantiate abuse or neglect.

The Substance Exposed Pregnancy Initiative of Connecticut (SEPI-CT), run by DMHAS with DCF and Wheeler, coordinates care and helps families build a Family Care Plan, which is Connecticut’s version of a federally required Plan of Safe Care. The PROUD program serves pregnant and postpartum people with substance use disorders in the Greater Hartford and New Britain areas, and the statewide Women’s REACH program pairs families with recovery navigators who have lived experience.

For people involved with the courts or returning from incarceration, treatment can begin through the same Access Line and assessment system. Families looking to help someone can start with information for families or read about methadone and pregnancy.

Naloxone and Overdose Safety in Connecticut

Naloxone, the medication that reverses an opioid overdose, is easy to get in Connecticut. Pharmacists certified by the state can both prescribe and dispense it, so you can walk into many pharmacies without a separate prescription, and any provider who can prescribe an opioid can also prescribe naloxone.

DMHAS-funded regional organizations, syringe service programs, and harm-reduction sites distribute it free along with training, and the state offers a free Naloxone and Overdose Response App (NORA) through the Department of Public Health.

Connecticut’s Good Samaritan law (Public Act 11-210) is meant to protect someone who seeks medical help in good faith for a person they believe is overdosing. A return to use can happen with a chronic condition and is something to plan for, not a failure. Carrying naloxone is basic safety. Learn the warning signs and response steps for opioid and methadone overdose.

Common Questions About Treatment in Connecticut

Does HUSKY Health (Medicaid) cover methadone and Suboxone?

Yes, Connecticut’s HUSKY Health program covers all three FDA-approved medications for opioid use disorder, including methadone, buprenorphine and Suboxone, and naltrexone or Vivitrol. Because HUSKY runs fee-for-service rather than through managed care plans, coverage is relatively consistent across the state (Connecticut Department of Social Services).

Can I start Suboxone by telehealth in Connecticut?

In many cases, yes. As of June 2026, federal rules allow buprenorphine to be started through telehealth, sometimes by phone, without a prior in-person visit. These flexibilities run through the end of 2026 and are still being finalized, so confirm current options with the provider you choose.

Do I have to go to a clinic every day for methadone?

At first, usually yes, but not forever. Methadone for opioid use disorder is dispensed through an opioid treatment program, and federal rules updated in 2024 allow up to a 28-day take-home supply for patients who are stable in treatment. The program decides take-home eligibility based on how treatment is going.

What is the fastest way to get help today?

Call Connecticut’s DMHAS Access Line at 1-800-563-4086, any hour. Staff can connect you to a same-day walk-in assessment center and check real-time bed availability. You can also call a provider directly from the listings on this page.

Is methadone just trading one drug for another?

No, this is a common misunderstanding. Methadone and buprenorphine are prescribed, steady-dose medications that stop withdrawal and cravings without the cycle of intoxication, and they are an evidence-based standard of care. You can read more in our questions and answers about methadone.

Last reviewed and disclosures

Last reviewed June 2026.

Sources:

Not a provider: Methadone Centers is an informational directory and education resource, not a medical provider, and does not offer medical advice, diagnosis, or treatment. Always consult a licensed clinician about your care.

Helpline disclosure: Calls to the helpline featured on this site may be answered by a sponsored treatment provider. Using this directory or helpline is free, and you are never under any obligation to enter treatment with any particular provider.

By Gayle Morris

Last Updated: August 20, 2026